Australia TGA ARTG record

Clinical chemistry-specific protein IVDs

Australia TGA ARTG Registered Device · Qiagen Pty Ltd · QIAGEN Sciences LLC · Class IIb · Started March 03, 2023

Good Name: Qiagen Pty Ltd - Clinical chemistry-specific protein IVDs

Device classification

Risk Class: Class IIb
Product Type: IVD
ARTG Category: IVD

Registration information

Start Date: March 03, 2023
Effective Date: March 03, 2023

Sponsor

Name: Qiagen Pty Ltd

Manufacturer

Name: QIAGEN Sciences LLC
Country: United States of America
Address: 19300 Germantown Road, Germantown, MD, 20874

Intended purpose

IVDs for the qualitative detection of interferon-gamma for assessing cell-mediated immune (CMI) responses

About this record

Access comprehensive regulatory information for Clinical chemistry-specific protein IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Qiagen Pty Ltd, manufactured by QIAGEN Sciences LLC in United States of America. The device registration started on March 03, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.